Kymera Therapeutics, Inc.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
KYMR$131.73+2.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item 5. Other Information.
There were no trading arrangements for the purchase or sale of our securities entered into, modifiedor terminated by our Directors or Officers during the third quarter of 2026.
Item 6. E
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.